February 2, 2023
The Battle Rages On
Before I get into my thoughts and commentary on the results released by Lilly and Novo Nordisk let’s start with a nice short rant. Will someone please tell these analysts and uninformed journalists that Wegovy and Ozempic are basically the same drug used for two different indications, one for diabetes the other for weight loss. Trulicity and now Mounjaro are both diabetes drugs, but each does very well in the weight loss are. It won’t be long before Mounjaro is approved for weight loss allowing Lilly and Novo to trade punches yet again.
Yes, the diabetes versions of . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
